Clinical Trial Update: Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating intravenous tenecteplase for acute ischemic stroke in patients with recent DOAC use; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Acute Ischemic Stroke | Phase 3 | Status: RECRUITING